Skip to content

Nevirapine / rifampicin interaction linked to higher recurrence of TB in people on ART

Most patients in darunavir monotherapy trial stay fully suppressed

Mobile phone messages improve adherence and HIV control in Kenyan trial

Photo by Erik Hersman. Creative Commons via Flickr.

Protease inhibitor monotherapy in African setting results in viral load, but not CD4, failure in the short term

Persistent low-level viral load is associated with failure, but risk is small

Study confirms that the sooner treatment is started the better

One-pill regimen improves adherence and reduces hospitalisation in insured US patients

Bone loss common in patients with HIV, and often progresses

Anti-nausea drug has anti-HIV effect too